Get Quote

Home > Healthcare > Cancer Biomarkers Market

Cancer Biomarkers Market Size Growth - By Type (Breast Cancer, Prostate Cancer), By Biomolecule (Genetic, Epigenetic, Metabolic, Proteomic), By Application, By Technology, and By Region: Statistics Reports, Supply & Demand Analysis, Global Opportunity 2024-2030

Report ID: GIH 1039  |  Sep 2024  |  Format:

   Request Customization
Report Description
Table Of Contents
Research Methodology

Share this link via:

Add Citation

Global Industry Hub. (Sep, 2024). Cancer Biomarkers Market Share & Forecast, 2024 - 2030 Global Industry Hub. Retrieved Nov 20, 2024, from https://www.globalindustryhub.com/industry-report/cancer-biomarkers-market

Global Market Synopsis, Forecast, Trend, and Growth Up To 2030

Cancer Biomarkers Market size was valued at US$ 30.45 Bn in 2023, registering a CAGR of 12.8% during the forecast period (2024-2030), and the market is projected to be worth US$ 69.85 Bn by 2030.
 

Cancer Biomarkers Market Size
Get PDF Sample Report on -  Request Free Sample 

The report includes Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Market Updates, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprint by Global Industry Hub.

Cancer Biomarkers Market Scope:

  • A basic overview of the competitive landscape
  • A detailed breakdown of the regional market
  • A brief overview of market segmentation

Key Players: 

  • Abbott
  • QIAGEN
  • Thermo Fisher Scientific Inc
  • Affymetrix Inc
  • Illumina, Inc.
  • Agilent Technologies
  • F. Hoffmann-La Roche AG
  • Merck & Co. Inc
  • Hologic, Inc
  • Sino Biological Inc

Scope of the Report:

The Cancer Biomarkers market is divided based on product, end user, application, and region. Each category has various sub-segments, and current trends in each segment help producers target specific customers effectively.

Important Features of the Report:

  • Detailed analysis of the Cancer Biomarkers market
  • Fluctuating market dynamics
  • Historical, current, and projected market size
  • Recent industry trends
  • Competitive landscape
  • Strategies of key players
  • Potential growth segments/regions
  • A neutral perspective on market performance 

 Our Sample Report Includes:

  • Introduction, overview, and in-depth industry analysis updated for 2030.
  • A research report spanning over 150+ pages, including updated research.
  • Updated regional analysis for 2024 with the graphical representation of size, share, and trends.
  • An updated list of tables and figures.
  • Top market players with their business strategy, sales volume, and revenue analysis.

Reasons for buying this report:

  • Make informed decisions with analytical data
  • Understand key product segments
  • Identify market dynamics like drivers, restraints, trends, and opportunities
  • Analyze regional markets and stakeholder profiles

Market Segmentation -

  • Type Outlook

    • Breast cancer

    • Prostate cancer

    • Colorectal cancer

    • Cervical cancer

    • Liver cancer

    • Lung cancer

    • Others

  • Biomolecule Outlook

    • Genetic Biomarkers

    • Epigenetic Biomarkers

    • Metabolic Biomarkers

    • Proteomic Biomarkers

    • Others

  • Application Outlook

    • Drug discovery and Development

    • Diagnostics

    • Personalized medicine

    • Others

  • Technology Outlook

    • Imaging Technology

    • OMICS

  • Regional Outlook

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • Thailand

      • South Korea

    • Latin America

      • Brazil

      • Argentina

    • Middle East and Africa (MEA)

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Key players in the industry are adopting growth strategies like partnerships, collaborations, mergers and acquisitions, and awareness programs to strengthen their market presence. The report also lists industry players for end users, facilitating communication between manufacturers and consumers.

Recent Market Updates:

  • In March of 2023, LES LABORATOIRES SERVIER partnered with QIAGEN to create a novel mIDH1 companion diagnostic test to advance their Hemato-Oncology Portfolio. This collaboration focuses on developing a test to identify acute myeloid leukemia patients.

  • In April 2021, Roche launched the Elecsys Anti-p53 immunoassay for diagnosing various cancers, available in CE mark-accepting markets. This test quantifies anti-p53 antibodies in serum and plasma, aiding physicians in diagnosing throat, bowel, and breast cancers when used with other diagnostics.

Regional Analysis for Cancer Biomarkers Market:

  • North America(the United States, Canada, and Mexico)
  • Europe(Germany, France, UK, Russia, and Italy)
  • Asia-Pacific(China, Japan, Korea, India, and Southeast Asia)
  • South America(Brazil, Argentina, Colombia, etc.)
  • The Middle East and Africa(Saudi Arabia, UAE, Egypt, Nigeria, and South Africa) 

The Research Provides Answers to the Following Key Questions:

  1. What is the expected growth rate of the Cancer Biomarkers market from 2024 to 2030?
  2. What are the major driving forces shaping the industry?
  3. Who are the major vendors dominating the market, and what are their winning strategies?
  4. What trends can business owners expect in the coming years?
  5. What threats and challenges might hinder industry progress?
  6. What opportunities can business owners capitalize on from 2024 to 2030?
Choose License
Report Insights
  • Base Year: 2023
  • Companies covered: 45
  • Countries covered: 36
  • Tables & Figures: 260
  • Pages: 150
Report Highlights

Updated Version & Immediate Delivery Available

Your personal details are safe with us, Privacy Policy.

Thank You!

You'll get the sample you asked for by email. Remember to check your spam folder as well. If you have any further questions or require additional assistance, feel free to let us know via-

+1 302 524 9787   +91 952 924 9024 [email protected]

Global Industry Hub
Cancer Biomarkers Market Share & Forecast, 2024 - 2030

 03 Sep 2024 This Report Contains the Latest Market Numbers, Statistics & Data Aavailable

Global Industry Hub is a place known for its smart ideas and great work in studying markets. We promise to give the best information to businesses so they can understand what's happening in the market and plan for the future.

Quick Links
footer
Reach Us
footer

Office 201, Gavthan, Nimgaon Ghana, Near Bhalawani, Ahmednagar, Maharashtra, India, 414103

+1 302 524 9787

  +91 952 924 9024

[email protected]

Global Industry Hub © 2024. All rights reserved.